Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8JT9

Human VMAT2 complex with ketanserin

Summary for 8JT9
Entry DOI10.2210/pdb8jt9/pdb
EMDB information36637
DescriptorSynaptic vesicular amine transporter, 3-[2-[4-(4-fluorophenyl)carbonylpiperidin-1-yl]ethyl]-1~{H}-quinazoline-2,4-dione (2 entities in total)
Functional Keywordstransporter1, transport protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight49482.28
Authors
Jiang, D.H.,Wu, D. (deposition date: 2023-06-21, release date: 2023-11-29, Last modification date: 2025-06-25)
Primary citationWu, D.,Chen, Q.,Yu, Z.,Huang, B.,Zhao, J.,Wang, Y.,Su, J.,Zhou, F.,Yan, R.,Li, N.,Zhao, Y.,Jiang, D.
Transport and inhibition mechanisms of human VMAT2.
Nature, 626:427-434, 2024
Cited by
PubMed Abstract: Vesicular monoamine transporter 2 (VMAT2) accumulates monoamines in presynaptic vesicles for storage and exocytotic release, and has a vital role in monoaminergic neurotransmission. Dysfunction of monoaminergic systems causes many neurological and psychiatric disorders, including Parkinson's disease, hyperkinetic movement disorders and depression. Suppressing VMAT2 with reserpine and tetrabenazine alleviates symptoms of hypertension and Huntington's disease, respectively. Here we describe cryo-electron microscopy structures of human VMAT2 complexed with serotonin and three clinical drugs at 3.5-2.8 Å, demonstrating the structural basis for transport and inhibition. Reserpine and ketanserin occupy the substrate-binding pocket and lock VMAT2 in cytoplasm-facing and lumen-facing states, respectively, whereas tetrabenazine binds in a VMAT2-specific pocket and traps VMAT2 in an occluded state. The structures in three distinct states also reveal the structural basis of the VMAT2 transport cycle. Our study establishes a structural foundation for the mechanistic understanding of substrate recognition, transport, drug inhibition and pharmacology of VMAT2 while shedding light on the rational design of potential therapeutic agents.
PubMed: 38081299
DOI: 10.1038/s41586-023-06926-4
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.97 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon